Publications

• Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells.
  February 25, 2007.
  Gilner JB, Walton WG, Gush K, Kirby SL
  
  
• Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.
  June 15,2004.
  Lindley C, Shea T, McCune J, Shord S, Decker J, Harvey D, Petros WP, Garbriel D, Serody J, Kirby S, Wiley J.
  
  
• Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.
  September, 2002.
  Suwanmanee T, Sierakowska H, Lacerra G, Svasti S, Kirby S, Walsh CE, Fucharoen S, Kole R.
  
  
• Gene correction in hematopoietic progenitor cells by homologous recombination.
  December 5, 2000.
  Hatada S, Nikkuni K, Bentley SA, Kirby S, Smithies O.
  
  
• Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation.
  June 15, 2000.
  Kirby S, Walton W, Smithies O.
  
  
• Comparison of G-CSF Mobilized Peripheral Blood Progenitor Cells and G-CSF-Stimulated Bone Marrow as a Source of Stem Cells in HLA-matched Sibling Transplantation. Biology of Blood and Marrow Transplantation
  .February, 2000.
  Jonathan S. Serody, Scotty D. Sparks, Yuhua Lin, Eileen J. Capel, Sharon H. Bigelow, Suzanne L. Kirby, Don A. Gabriel, Joseph M. Wiley, Mark E. Brecher, Michael J. Schell, James Folds, Thomas C. Shea1,
  
  
• Bone marrow: target for gene transfer.
  December 15, 1999.
  Kirby SL.
  
  
• Serody, JS, Cook, DN, Kirby, SL, Reap, E, Shea, T and Frelinger, JA
  Murine T lymphocytes incapable of producing MIP-1Alpha are impaired in causing GVHD across A class I but not class II MHC barrier.
  Blood 93:43-50 (1999).
  
  
• Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene
  September 2, 1996.
  Suzanne L. Kirby, Donald N. Cook, William Walton, and Oliver Smithies
  
  
• Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
  November 1996.
  P. Leif Bergsagel, Marta Chesi, Elena Nardini, Leslie A. Brents, Suzanne L. Kirby, W. Michael Kuehl
  
  
• A mouse model for beta 0-thalassemia.
  December 5, 1995.
  Yang B, Kirby S, Lewis J, Detloff PJ, Maeda N, Smithies O.
  
  
• Cook, DN, Beck, MA, Coffman, TM, Kirby, SL, Sheridan, JF, Pragnell, IB, and Smithies, O.
  Requirement of MIP-1a for Inflammatory Response to Viral Infection.
  Science 269:1583-1585 (1995).
  
  
• Xyloside effects on in vitro hematopoiesis: functional and biochemical studies.
  July 1991.
  Kirby SL, Bentley SA.
  


Home
Lineberger Cancer Center Website